Cytogel Pharma, LLC

Amendment

CIK: 0001491841·Pharmaceuticals·CONNECTICUT·Filed: May 21, 2021

Total Offering

$25,000,000

Amount Sold

$956,905

Investors

12

First Sale

Sep 27, 2019

Offering Details

Type: Equity
Exemptions: Rule 506(b)
Entity Type: Limited Liability Company
Non-Accredited Investors: No

Related Persons

Name	Role
C. Dean Maglaris	Related Person
William M. Carello	Related Person
Cassandra Klimp	Related Person
Frederick W. Telling	Related Person
Steven Chrust	Related Person
Theodore Maione	Related Person

Company

Cytogel Pharma, LLC

3 Thorndal Circle

Darien, CT, 06820

203-966-9867

SEC Filing

0001062993-21-004957

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.